Načítá se...
C‐Jun N‐terminal kinase signalling pathway in response to cisplatin
Cisplatin (cis diamminedichloroplatinum II, cDDP) is one of the most effective cancer chemotherapeutic agents and is used in the treatment of many types of human malignancies. However, inherent tumour resistance is a major barrier to effective cisplatin therapy. So far, the mechanism of cDDP resista...
Uloženo v:
| Vydáno v: | J Cell Mol Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5082413/ https://ncbi.nlm.nih.gov/pubmed/27374471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12908 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|